These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 19715304)
21. Decisions, decisions: beta-catenin chooses between adhesion and transcription. Harris TJ; Peifer M Trends Cell Biol; 2005 May; 15(5):234-7. PubMed ID: 15866026 [TBL] [Abstract][Full Text] [Related]
22. Critical factors in the development of fluorescence polarization-based peptide binding assays: an equilibrium study monitoring specific peptide binding to soluble HLA-A*0201. Buchli R; Vangundy RS; Giberson CF; Hildebrand WH J Immunol Methods; 2006 Jul; 314(1-2):38-53. PubMed ID: 16844138 [TBL] [Abstract][Full Text] [Related]
23. Decoding the dynamics of BCL9 triazole stapled peptide. Gaikwad V; Choudhury AR; Chakrabarti R Biophys Chem; 2024 Apr; 307():107197. PubMed ID: 38335808 [TBL] [Abstract][Full Text] [Related]
24. Design of triazole-stapled BCL9 α-helical peptides to target the β-catenin/B-cell CLL/lymphoma 9 (BCL9) protein-protein interaction. Kawamoto SA; Coleska A; Ran X; Yi H; Yang CY; Wang S J Med Chem; 2012 Feb; 55(3):1137-46. PubMed ID: 22196480 [TBL] [Abstract][Full Text] [Related]
25. Heterogeneous transition metal-based fluorescence polarization (HTFP) assay for probing protein interactions. Riechers A; Schmidt J; König B; Bosserhoff AK Biotechniques; 2009 Oct; 47(4):837-44. PubMed ID: 19852767 [TBL] [Abstract][Full Text] [Related]
26. The first armadillo repeat is involved in the recognition and regulation of beta-catenin phosphorylation by protein kinase CK1. Bustos VH; Ferrarese A; Venerando A; Marin O; Allende JE; Pinna LA Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19725-30. PubMed ID: 17172446 [TBL] [Abstract][Full Text] [Related]
27. Binding assays with artificial tethered membranes using surface plasmon resonance. Wiltschi B; Knoll W; Sinner EK Methods; 2006 Jun; 39(2):134-46. PubMed ID: 16857384 [TBL] [Abstract][Full Text] [Related]
28. LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction. Li J; Chen X; Ding X; Cheng Y; Zhao B; Lai ZC; Al Hezaimi K; Hakem R; Guan KL; Wang CY Cell Rep; 2013 Dec; 5(6):1650-63. PubMed ID: 24360964 [TBL] [Abstract][Full Text] [Related]
29. Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction. Wang Z; Zhang M; Luo W; Zhang Y; Ji H J Med Chem; 2021 May; 64(9):5886-5904. PubMed ID: 33902288 [TBL] [Abstract][Full Text] [Related]
30. Time-resolved fluorescence resonance energy transfer and surface plasmon resonance-based assays for retinoid and transthyretin binding to retinol-binding protein 4. Sharif O; Hu H; Klock H; Hampton EN; Nigoghossian E; Knuth MW; Matzen J; Anderson P; Trager R; Uno T; Glynne RJ; Azarian SM; Caldwell JS; Brinker A Anal Biochem; 2009 Sep; 392(2):162-8. PubMed ID: 19482004 [TBL] [Abstract][Full Text] [Related]
31. Utilization of fluorescence polarization and time resolved fluorescence resonance energy transfer assay formats for SAR studies: Src kinase as a model system. Newman M; Josiah S J Biomol Screen; 2004 Sep; 9(6):525-32. PubMed ID: 15452339 [TBL] [Abstract][Full Text] [Related]
32. The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis. Vafaizadeh V; Buechel D; Rubinstein N; Kalathur RKR; Bazzani L; Saxena M; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G Oncogene; 2021 Oct; 40(43):6195-6209. PubMed ID: 34545187 [TBL] [Abstract][Full Text] [Related]
33. Crystal structure analysis of the PHD domain of the transcription co-activator Pygopus. Nakamura Y; Umehara T; Hamana H; Hayashizaki Y; Inoue M; Kigawa T; Shirouzu M; Terada T; Tanaka A; Padmanabhan B; Yokoyama S J Mol Biol; 2007 Jun; 370(1):80-92. PubMed ID: 17499269 [TBL] [Abstract][Full Text] [Related]
34. High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1. Lokesh GL; Rachamallu A; Kumar GD; Natarajan A Anal Biochem; 2006 May; 352(1):135-41. PubMed ID: 16500609 [TBL] [Abstract][Full Text] [Related]
35. Fluorescence polarization: analysis of carbohydrate-protein interaction. Kakehi K; Oda Y; Kinoshita M Anal Biochem; 2001 Oct; 297(2):111-6. PubMed ID: 11673876 [TBL] [Abstract][Full Text] [Related]
36. Structure-Based Optimization of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction. Zhang M; Wang Z; Zhang Y; Guo W; Ji H J Med Chem; 2018 Apr; 61(7):2989-3007. PubMed ID: 29566337 [TBL] [Abstract][Full Text] [Related]
37. A synthetic peptide corresponding to residues 301-320 of human Wnt-1 promotes PC12 cell adhesion and hippocampal neural stem cell differentiation. Kajiwara K; Kamamoto M; Ogata S; Tanihara M Peptides; 2008 Sep; 29(9):1479-85. PubMed ID: 18584914 [TBL] [Abstract][Full Text] [Related]
38. A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein-protein interactions by fluorescence polarization. Roehrl MH; Wang JY; Wagner G Biochemistry; 2004 Dec; 43(51):16056-66. PubMed ID: 15610000 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors. Sang P; Zhang M; Shi Y; Li C; Abdulkadir S; Li Q; Ji H; Cai J Proc Natl Acad Sci U S A; 2019 May; 116(22):10757-10762. PubMed ID: 31088961 [TBL] [Abstract][Full Text] [Related]
40. An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors. Chopra P; Nanda K; Chatterjee M; Bajpai M; Dastidar SG; Ray A Anal Biochem; 2008 Sep; 380(1):143-5. PubMed ID: 18570885 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]